Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideEWEdwards Lifesciences
FinDog View：Neutral
MRKMerck & Co.
FinDog View：Neutral
| Metric | EW | MRK |
|---|
| Close | 92.01 | 149.52 |
| Market Cap | $53.6B | $371B |
| 1M | +6.59% | +2.90% |
| P/E (TTM) | 53.7 | 117.2 |
| Forward P/E | 31.0 | 19.6 |
| P/E 5-Yr Percentile | 100 | 81 |
| P/S | 8.3 | 5.6 |
| P/B | 5.1 | 8.9 |
| Dividend Yield | — | 2.87% |
| Latest Quarter Revenue | $1.7B | $16.6B |
| Revenue YoY | +13.6% | +5.1% |
| Gross Margin | 77.5% | 73.5% |
| Latest Quarter EPS | 0.42 | -0.54 |
| Avg Post-Earnings Move | ±3.9% | ±1.7% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | 2 / 2 | — |
| Shareholder Yield | 2.25% | 3.37% |
| 90-Day Net Insider Buying | −$3.5M | −$30.0M |
EW · Revenue, Last 8 Quarters ($B)
MRK · Revenue, Last 8 Quarters ($B)
